Profile image
By ProactiveInvestors (Reporter)
Contributor profile | More stories
Story Views

Last Hour:
Last 24 Hours:

VolitionRx outgrows its old R&D facilities

Wednesday, October 26, 2016 5:37
% of readers think this story is Fact. Add your two cents.

Belgium-based life sciences company VolitionRx Ltd (NYSEMKT:VNRX) has acquired a new research and development (R&D) facility in the Wallonia region of Belgium for €1.2mln.

The company expects to move into the new facility, in the Crealys Science Park in Les Isnes, in March of next year.

The company was running out of space at its current facilities, so the shift to new premises will give the company the space to carry out clinical trials with additional lab machines and to fit in a few more scientists.

“We are looking forward to moving into our new R&D facility as we are exceeding maximum capacity at our current facilities. We believe that this exciting upgrade will allow us to accelerate our clinical trials and expedite the commercialization of our products” said Dr Gaetan Michel, chief executive officer of Belgian Volition.

The company also revealed that Dr Philippe Willemsen has been lured over from Promethera Biosciences to become chief operating officer for VolitionRx’s wholly-owned subsidiary, Belgian Volition SPRL.

“He brings with him a wealth of experience and joins us at an exciting time as we prepare to launch our first Nu.QTM test. His appointment to manage operations in Belgium will allow me to focus on my role as global product manager for the Nu.QTM Colorectal Cancer Screening Triage Test (blood test), for which we expect to receive CE marking later this year,” said Dr Michel.

Story by ProactiveInvestors


We encourage you to Share our Reports, Analyses, Breaking News and Videos. Simply Click your Favorite Social Media Button and Share.

Report abuse


Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories



Top Global


Top Alternative




Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.